ESC 365 - Riociguat: mechanism of action and efficacy in patients with pulmonary arterial hypertension

ESC Professional Premium Access

Riociguat: mechanism of action and efficacy in patients with pulmonary arterial hypertension

Session: Advances in cardiovascular pharmacotherapy: reaching the unreachable?

Topic: Pharmacology and Pharmacotherapy

Speaker: Doctor M. Escribano Subias (Madrid, ES)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Maria Pilar Escribano Subias

12th of October University Hospital, Madrid (Spain)

4 presentations

5 followers

4 more presentations in this session

Pharmacological effects of bempedoic acid: clinical implications

Speaker: Professor A. Catapano (Milan, IT)

Statins prevent LV dysfunction in patients receiving chemotherapy regimens containing anthracyclines

Speaker: Doctor M. Scherrer-Crosbie (Philadelphia, US)

Sarcomere-targeted therapy for treatment of oHCM

Speaker: Doctor A. Pantazis (Harefield, Uxbridge, GB)

Advances in cardiovascular pharmacotherapy: reaching the unreachable? - discussion

Access the full session

Advances in cardiovascular pharmacotherapy: reaching the unreachable?

Speakers: Doctor M. Escribano Subias, Professor A. Catapano, Doctor M. Scherrer-Crosbie, Doctor A. Pantazis

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources